MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Validation of the Neuroprotective Potential of SLP-2 against alpha-synuclein neuropathology in a Mouse Model of Parkinson’s Disease

    C. Bolduc, M. Lorente Picón, S. Laouafa, J. Soliz, I. Pichler, M. Lévesque (Québec, Canada)

    Objective: We aim to validate the neuroprotective potential of SLP-2 against α-syn neuropathology and neurodegeneration of dopaminergic neurons in a mouse model of Parkinson’s disease.…
  • MDS Virtual Congress 2021

    Impact on Dyskinesia in Advanced Parkinson’s Disease Patients Treated with LCIG: Analysis from the COSMOS Study

    A. Fasano, C. Spanaki, T. Gurevich, M. Simu, L. Bergmann, J. Parra, P. Sanchez Vega, O. Sanchez-Soliño, N. Kovács (Toronto, Canada)

    Objective: Analyze the impact of levodopa-carbidopa intestinal gel (LCIG) treatment on dyskinesia duration and severity in advanced Parkinson’s disease (APD) patients participating in the COSMOS…
  • MDS Virtual Congress 2021

    Effect of the mGlu2/3 orthosteric agonist LY-404,039 on abnormal involuntary movements and parkinsonism in the 6-OHDA-lesioned rat

    W. Kang, I. Frouni, C. Kwan, L. Desbiens, D. Bédard, A. Hamadjida, P. Huot (Montreal, Canada)

    Objective: To assess the effect of LY-404,039 on dyskinesia and parkinsonism in the 6-hydroxydopamine (6-OHDA)-lesioned rat model of Parkinson’s disease (PD). Background: LY-404,039 is an…
  • MDS Virtual Congress 2021

    Adherence to medication among Serbian Parkinson’s disease patients: a cross-sectional study

    A. Milovanović, B. Radojević, NT. Dragašević-Mišković, M. Svetel, I. Petrović, A. Tomić-Pešić, M. Savić, D. Stanisavljević, VS. Kostić (Belgrade, Serbia)

    Objective: This study aimed to explore patients’ adherence to antiparkinsonian medication, and to determine factors associated with low adherence among Serbian PD patients. Background: Adherence…
  • MDS Virtual Congress 2021

    Effectiveness of opicapone in Parkinson’s disease patients with motor fluctuations according to baseline use of monoamine-oxidase-B inhibitors (MAO-B) and dopamine agonists (DA): findings from the real-world OPTIPARK study

    H. Reichmann, T. Warnecke, A. Lees, D. Martins, D. Magalhães, J. Rocha, P. Soares-da-Silva (Dresden, Germany)

    Objective: This post-hoc analysis evaluated the effectiveness of opicapone (OPC) in Parkinson’s disease (PD) patients with motor fluctuations (MF) according to baseline use of monoamine-oxidase-B…
  • MDS Virtual Congress 2021

    Local Field Potentials (LFP) used to guide treatment of biphasic dyskinesias in a patient with Parkinson’s Disease (PD)

    O. Vaou, C. Harrington, S. Stanslaski, R. Cosgrove, A. Depold Hohler (Brighton, USA)

    Objective: To identify, characterize and treat dyskinesias and off time in a patient with PD via the use of gamma and beta peak LFP using…
  • MDS Virtual Congress 2021

    Laryngeal Electromyography Findings in patients with Multiple System Atrophy

    F. Gandor, A. Vogel, A. Haghikia, G. Ebersbach, T. Warnecke, D. Gruber (Beelitz-Heilstätten, Germany)

    Objective: to systematically evaluate laryngeal electromyography findings, correlate them to laryngeal movement disorders assessed by a systematic task-protocol performed during FEES and clinical laryngeal symptoms.…
  • MDS Virtual Congress 2021

    Unusual Progressive Supranuclear Palsy: a case report

    L. Megherbi, H. Si Ahmed, S. Daoudi (Tizi Ouzou, Algeria)

    Objective: Introduction: Progressive supranuclear palsy (PSP) is a rare brain condition. It is predominantly a sporadic disease that occurs between 45 and 75 years of…
  • MDS Virtual Congress 2021

    Lateralized Tau Pathology in a Case of Lewy Body Dementia with Corticobasal Syndrome

    D. Coughlin, H. Coslett, C. Mcmillan, J. Phillips, E. Lee, J. Trojanowski, M. Grossman, D. Irwin (San Diego, USA)

    Objective: To measure bilateral in vivo and postmortem tau pathology in a well-characterized patient presenting with corticobasal syndrome (CBS) due to underlying neocortical stage Lewy…
  • MDS Virtual Congress 2021

    FINANCIAL COST OF PARKINSON’S DISEASE IN BRAZIL IN THE LAST 10 YEARS

    R. Oliveira, S. Moura, L. Cruz, N. Cruz (Salvador, Brazil)

    Objective: Analyzing the financial cost of Parkinson's Disease in Brazil in the last 10 years Background: The Parkinson's disease is a neurodegenerative disease that when…
  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley